56 completed, 20 terminated, 3 withdrawn, 1 active not recruiting. 42 Phase 1, 33 Phase 2, 12 Not applicable, 1 Early Phase 1, 1 Phase 3.
Follow Recurrent Cutaneous T-Cell Non-Hodgkin Lymphoma: new trials by email Literature Review of Recurrent Cutaneous T-Cell Non-Hodgkin Lymphoma trials Research Report on Recurrent Cutaneous T-Cell Non-Hodgkin Lymphoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Yttrium Y 90 Basiliximab and Combination Chemotherapy Before Stem Cell Transplant in Treating Patients With Mature T-cell Non-Hodgkin Lymphoma Yttrium Y 90 Basiliximab, Carmustine, Etoposide - Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma, Recurrent Mature T- and NK-Cell Non-Hodgkin Lymphoma | Phase 1 | Completed | City of Hope Medical Center | 20 | 2020-06-08 | 2025-03-20 |
| Durvalumab With or Without Lenalidomide in Treating Patients With Relapsed or Refractory Cutaneous or Peripheral T Cell Lymphoma Durvalumab, Laboratory Biomarker Analysis, Lenalidomide - Folliculotropic Mycosis Fungoides, Recurrent Cutaneous T-Cell Non-Hodgkin Lymphoma | Phase 1 / Phase 2 | Recruiting | City of Hope Medical Center | 78 | 2017-03-08 | 2026-07-31 |
| Genetically Modified Peripheral Blood Stem Cell Transplant in Treating Patients With HIV-Associated Non-Hodgkin or Hodgkin Lymphoma carmustine, cytarabine, melphalan - Adult Nasal Type Extranodal NK/T-cell Lymphoma, AIDS-related Diffuse Large Cell Lymphoma | Not applicable | Withdrawn | Fred Hutchinson Cancer Center | 2015-02-01 | 2015-05-07 | |
| CPI-613 and Bendamustine Hydrochloride in Treating Patients With Relapsed or Refractory T-Cell Non-Hodgkin Lymphoma or Hodgkin Lymphoma 6,8-bis(benzylthio)octanoic acid, bendamustine hydrochloride - Adult Lymphocyte Depletion Hodgkin Lymphoma, Adult Lymphocyte Predominant Hodgkin Lymphoma | Phase 1 | Completed | Wake Forest University Health Sciences | 16 | 2014-09-01 | 2024-02-13 |
| Dose Monitoring of Busulfan and Combination Chemotherapy in Hodgkin or Non-Hodgkin Lymphoma Undergoing Stem Cell Transplant busulfan, etoposide, cyclophosphamide - Adult Grade III Lymphomatoid Granulomatosis, Adult Nasal Type Extranodal NK/T-cell Lymphoma | Early Phase 1 | Completed | Case Comprehensive Cancer Center | 33 | 2014-03-01 | 2015-08-13 |
| Single or Double Donor Umbilical Cord Blood Transplant in Treating Patients With High-Risk Hematologic Malignancies cyclophosphamide, fludarabine phosphate, mycophenolate mofetil - Accelerated Phase Chronic Myelogenous Leukemia, Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome | Phase 2 | Withdrawn | University of Medicine and Dentistry of New Jersey | 2014-01-01 | 2016-07-14 | |
| MORAb-004 in Treating Young Patients With Recurrent or Refractory Solid Tumors or Lymphoma anti-endosialin/TEM1 monoclonal antibody MORAb-004, pharmacological study, laboratory biomarker analysis - Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma | Phase 1 | Completed | Morphotek | 27 | 2013-11-01 | 2016-01-08 |
| Donor T Cells After Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies therapeutic allogeneic lymphocytes, laboratory biomarker analysis - Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities | Phase 2 | Completed | University of Chicago | 77 | 2013-04-04 | 2019-08-07 |
| Silicon Phthalocyanine 4 and Photodynamic Therapy in Stage IA-IIA Cutaneous T-Cell Non-Hodgkin Lymphoma silicon phthalocyanine 4, photodynamic therapy, pharmacological study - Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma, Recurrent Mycosis Fungoides/Sezary Syndrome | Phase 1 | Completed | Kevin Cooper MD | 11 | 2013-04-01 | 2019-05-16 |
| Dose-Escalation Trial of Carfilzomib With and Without Romidepsin in Cutaneous T-Cell Lymphoma carfilzomib, romidepsin, laboratory biomarker analysis - Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma, Recurrent Mycosis Fungoides/Sezary Syndrome | Phase 1 | Terminated | Northwestern University | 7 | 2013-03-22 | 2019-08-29 |
| Brentuximab Vedotin + Rituximab as Frontline Therapy for Pts w/ CD30+ and/or EBV+ Lymphomas brentuximab vedotin, rituximab, laboratory biomarker analysis - Adult Grade III Lymphomatoid Granulomatosis, Adult Nasal Type Extranodal NK/T-cell Lymphoma | Phase 1 / Phase 2 | Terminated | Northwestern University | 20 | 2013-03-05 | 2021-09-01 |
| Ipilimumab and Local Radiation for Selected Solid Tumors Ipilimumab, Radiation therapy - Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma | Phase 1 | Terminated | Stanford University | 3 | 2013-02-01 | 2024-01-24 |
| Vaccine Therapy in Preventing Cytomegalovirus Infection in Patients With Hematological Malignancies Undergoing Donor Stem Cell Transplant tetanus-CMV fusion peptide vaccine, laboratory biomarker analysis - Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission | Phase 1 | Completed | City of Hope Medical Center | 36 | 2012-10-29 | 2024-04-02 |
| Mechanical Stimulation in Preventing Bone Density Loss in Patients Undergoing Donor Stem Cell Transplant management of therapy complications, musculoskeletal complications management/prevention - Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission | Not applicable | Withdrawn | Roswell Park Cancer Institute | 2012-05-01 | 2012-07-09 | |
| Lenalidomide With or Without Rituximab in Treating Patients With Progressive or Relapsed Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Prolymphocytic Leukemia, or Non-Hodgkin Lymphoma Previously Treated With Donor Stem Cell Transplant lenalidomide, rituximab, pharmacological study - Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma | Phase 2 | Terminated | Fred Hutchinson Cancer Center | 3 | 2012-05-01 | 2017-07-27 |
| Fludarabine Phosphate, Melphalan, and Low-Dose Total-Body Irradiation Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies fludarabine phosphate, melphalan, total-body irradiation - Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission | Phase 2 | Completed | Roswell Park Cancer Institute | 94 | 2012-02-28 | 2019-09-24 |
| Donor Peripheral Stem Cell Transplant in Treating Patients With Hematolymphoid Malignancies therapeutic allogeneic lymphocytes - Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(15;17)(q22;q12) | Phase 1 | Completed | Robert Lowsky | 16 | 2012-01-01 | 2023-11-22 |
| Etoposide, Filgrastim, and Plerixafor in Improving Stem Cell Mobilization in Treating Patients With Non-Hodgkin Lymphoma plerixafor, filgrastim, etoposide - Adult Acute Lymphoblastic Leukemia in Remission, Adult Grade III Lymphomatoid Granulomatosis | Not applicable | Terminated | Case Comprehensive Cancer Center | 25 | 2011-10-01 | 2019-06-14 |
| Cyclophosphamide for Prevention of Graft-Versus-Host Disease After Allogeneic Peripheral Blood Stem Cell Transplantation in Patients With Hematological Malignancies cyclophosphamide, cyclosporine, peripheral blood stem cell transplantation - Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission | Phase 2 | Completed | Fred Hutchinson Cancer Center | 43 | 2011-09-01 | 2017-05-19 |
| A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological Malignancies Fludarabine, Busulfan, Total Body Irradiation (TBI) - Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in Remission | Phase 2 | Completed | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | 40 | 2011-08-04 | 2026-04-15 |
Showing 20 of 81. Sign in to see all of them.
Lymphoma, T-Cell, Cutaneous (81) · Mycosis Fungoides (75) · Sezary Syndrome (75) · Leukemia, Lymphocytic, Chronic, B-Cell (70) · Lymphoma, Large B-Cell, Diffuse (69) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (68) · Lymphoma, B-Cell, Marginal Zone (67) · Lymphoma, Follicular (67) · Lymphoma, Mantle-Cell (65) · Burkitt Lymphoma (64) · Lymphoma, Non-Hodgkin (64) · Hodgkin Disease (61) · Lymphoma, Large-Cell, Immunoblastic (61) · Lymphoma, Large-Cell, Anaplastic (60) · Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (58)
Hemic and Lymphatic Diseases (81) · Immune System Diseases (81) · Immunoproliferative Disorders (81) · Lymphatic Diseases (81) · Lymphoma (81) · Lymphoproliferative Disorders (81) · Neoplasms (81) · Neoplasms by Histologic Type (81) · Lymphoma, T-Cell (76) · Hematologic Diseases (74) · Leukemia (74) · Leukemia, Lymphoid (74) · Lymphoma, B-Cell (71) · Chronic Disease (70) · Disease Attributes (70)
Peripheral Blood Stem Cell Transplantation (16) · Whole-Body Irradiation (16) · fludarabine phosphate (15) · Mycophenolic Acid (14) · Cyclosporine (10) · Cyclophosphamide (9) · Etoposide (8) · Busulfan (7) · Tacrolimus (7) · Rituximab (6) · Melphalan (5) · Therapeutics (5) · Transplantation (5) · Bortezomib (4) · Carmustine (4)
National Cancer Institute (NCI) (28) · Fred Hutchinson Cancer Center (18) · City of Hope Medical Center (6) · Case Comprehensive Cancer Center (5) · Roswell Park Cancer Institute (4) · Wake Forest University Health Sciences (3) · Northwestern University (2) · University of Washington (2) · Amir Mortazavi (1) · Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium (1) · Kevin Cooper MD (1) · Martin, Paul (1) · Mayo Clinic (1) · Morphotek (1) · Pierluigi Porcu (1)
United States (80) · Italy (7) · Germany (4) · Canada (2)
Brenda Sandmaier (4) · David Maloney (4) · Ajay Gopal (3) · Paul Martin (3) · George Chen (2) · Philip McCarthy (2) · Ramesh Ramanathan (2) · Ryotaro Nakamura (2) · Adam Petrich, MD (1) · Alain Rook (1) · Amir Mortazavi, MD (1) · Anas Younes (1) · Andre Goy (1) · Ann Woolfrey (1) · Barbara Pro, MD (1)
PMID 32499241, PMID 32632956, PMID 19900571, PMID 22250189, PMID 22259028, PMID 23256542, PMID 23393050, PMID 24241210, PMID 24474568, PMID 26213141, PMID 26764356, PMID 26853648, PMID 26943915, PMID 28270022, PMID 28314788, PMID 28817727, PMID 29292843, PMID 29572391, PMID 30562587, PMID 32628342, PMID 33420905, PMID 33492438, PMID 36282798, PMID 38838232, PMID 39951620
P30CA015704 (12), P01CA018029 (4), U01CA062491 (4), U01CA099168 (4), U01CA062487 (3), U01CA062502 (3), U01CA076576 (3), P01CA078902 (2), P30CA015083 (2), P30CA016058 (2), P30CA043703 (2), U01CA062505 (2), U01CA069912 (2), U01CA097452 (2), N01CM00039 (1)